The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections

Domenico Mattoscio; Chiara Casadio; Marzia Fumagalli; Mario Sideri; Susanna Chiocca

doi:10.3332/ecancer.2015.534

The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections

Domenico Mattoscio, Chiara Casadio, Marzia Fumagalli, Mario Sideri, Susanna Chiocca

Istituto Europeo di Oncologia

Research output: Contribution to journal › Article

Abstract

Human papillomaviruses (HPVs) infect stratified epithelium and are the causative agents of cervical cancer, the second most common cause of cancer-related death in women. A critical aspect that still persists in the HPV field is the selection of very sensitive and specific HPV diagnostic assays. Here, we provide evidence that the crucial small ubiquitin-like modifier (SUMO) E2-conjugating enzyme Ubc9 is strongly upregulated in cervical lesions. Ubc9 detection could thus be used in diagnosing and/or monitoring the progression of an HPV oncogenic infection.

Original language	English
Article number	534
Journal	ecancermedicalscience
Volume	9
DOIs	https://doi.org/10.3332/ecancer.2015.534
Publication status	Published - Apr 29 2015

Fingerprint

Keywords

Biomarker
Cervical cancer
HPV
HSIL
LSIL
SUMO
Ubc9

ASJC Scopus subject areas

Oncology
Cancer Research

Cite this

Mattoscio, D., Casadio, C., Fumagalli, M., Sideri, M., & Chiocca, S. (2015). The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections. ecancermedicalscience, 9, [534]. https://doi.org/10.3332/ecancer.2015.534

@article{ea33fbde5f0a45ce8e3841ad78891d02,

title = "The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections",

abstract = "Human papillomaviruses (HPVs) infect stratified epithelium and are the causative agents of cervical cancer, the second most common cause of cancer-related death in women. A critical aspect that still persists in the HPV field is the selection of very sensitive and specific HPV diagnostic assays. Here, we provide evidence that the crucial small ubiquitin-like modifier (SUMO) E2-conjugating enzyme Ubc9 is strongly upregulated in cervical lesions. Ubc9 detection could thus be used in diagnosing and/or monitoring the progression of an HPV oncogenic infection.",

keywords = "Biomarker, Cervical cancer, HPV, HSIL, LSIL, SUMO, Ubc9",

author = "Domenico Mattoscio and Chiara Casadio and Marzia Fumagalli and Mario Sideri and Susanna Chiocca",

year = "2015",

month = apr

day = "29",

doi = "10.3332/ecancer.2015.534",

language = "English",

volume = "9",

journal = "ecancermedicalscience",

issn = "1754-6605",

publisher = "Cancer Intellilgence",

}

TY - JOUR

T1 - The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections

AU - Mattoscio, Domenico

AU - Casadio, Chiara

AU - Fumagalli, Marzia

AU - Sideri, Mario

AU - Chiocca, Susanna

PY - 2015/4/29

Y1 - 2015/4/29

N2 - Human papillomaviruses (HPVs) infect stratified epithelium and are the causative agents of cervical cancer, the second most common cause of cancer-related death in women. A critical aspect that still persists in the HPV field is the selection of very sensitive and specific HPV diagnostic assays. Here, we provide evidence that the crucial small ubiquitin-like modifier (SUMO) E2-conjugating enzyme Ubc9 is strongly upregulated in cervical lesions. Ubc9 detection could thus be used in diagnosing and/or monitoring the progression of an HPV oncogenic infection.

AB - Human papillomaviruses (HPVs) infect stratified epithelium and are the causative agents of cervical cancer, the second most common cause of cancer-related death in women. A critical aspect that still persists in the HPV field is the selection of very sensitive and specific HPV diagnostic assays. Here, we provide evidence that the crucial small ubiquitin-like modifier (SUMO) E2-conjugating enzyme Ubc9 is strongly upregulated in cervical lesions. Ubc9 detection could thus be used in diagnosing and/or monitoring the progression of an HPV oncogenic infection.

KW - Biomarker

KW - Cervical cancer

KW - HPV

KW - HSIL

KW - LSIL

KW - SUMO

KW - Ubc9

UR - http://www.scopus.com/inward/record.url?scp=84930588519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930588519&partnerID=8YFLogxK

U2 - 10.3332/ecancer.2015.534

DO - 10.3332/ecancer.2015.534

M3 - Article

AN - SCOPUS:84930588519

VL - 9

JO - ecancermedicalscience

JF - ecancermedicalscience

SN - 1754-6605

M1 - 534

ER -

Access to Document

10.3332/ecancer.2015.534